Formerly incarcerated individuals have a higher risk and prevalence of HIV than the general population and encounter distinct care challenges that affect their health outcomes. While antiretroviral treatment (ART) should be available in correctional facilities, HIV-related clinical outcomes among formerly incarcerated individuals often worsen following release.
In this issue of eHIV Review, A Asa Clemenzi-Allen, MD, MAS, Assistant Professor of Medicine at the UCSF School of Medicine, reviews interventions designed to improve outcomes for formerly incarcerated people with or at risk for HIV. Dr. Clemenzi-Allen will address several unique challenges and considerations for this population by exploring the impact of COVID-19 policies on HIV care among criminal-legal-involved individuals, HIV screening and pre-exposure prophylaxis eligibility in incarcerated women, post-incarceration HIV care engagement, and the real-world outcomes of long-acting ART in diverse HIV populations.
Describe interventions that improve outcomes for formerly incarcerated people living with or at risk for HIV.
Assistant Clinical Professor of Medicine (Volunteer)
Division of HIV, ID and Global Medicine; University of California, San Francisco
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: September 12, 2024
Expiration date: September 11, 2026